Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Core Insights - Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare and difficult-to-treat diseases [3] - The company will participate in the Bank of America CNS Therapeutics Virtual Conference on December 8, 2025, at 12:35 PM ET [1][2] Company Overview - Catalyst Pharmaceuticals is committed to improving the lives of patients with rare diseases and has a proven track record of bringing life-changing treatments to market [3] - The company emphasizes accessibility and provides a comprehensive suite of support services to ensure patients receive necessary care [3] - Catalyst has a strong U.S. presence and is exploring strategic opportunities for global expansion [3] - The company was recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [3]